Investors Sue PACS Group (PACS) Amid Accusations of Medicare Fraud - Hagens Berman
San Francisco, California--(Newsfile Corp. - December 25, 2024) - PACS Group, Inc. (NYSE: PACS) and certain of its C-Suite officers are now entangled in a securities class action lawsuit, following allegations of misleading investors by engaging in deceptive Medicare practices. Hagens Berman urges investors in PACS Group who suffered substantial losses to submit your losses now. Class Period: Apr. 11, 2024 - Nov. 5, 2024 Lead Plaintiff Deadline: Jan. 13, 2025 Visit:...
2024-12-25 12:01 PM EST
Toronto-Dominion Bank (TD) Class Period Expanded in Securities Class Action Related To TD's Subsidiaries' Guilty Plea And Massive Fine - Hagens Berman
San Francisco, California--(Newsfile Corp. - December 21, 2024) - On December 11, 2024, a second investor in The Toronto-Dominion Bank (NYSE: TD) filed a class action lawsuit that expanded the Class Period in the related case to begin on March 7, 2022 and end on October 9, 2024. Both lawsuits follow the October 10, 2024 announcement by the U.S. Department of Justice that TD's U.S. subsidiaries had pleaded guilty to violating the Bank Secrecy Act and conspiracy to commit money laundering. The...
2024-12-21 10:09 AM EST
ASP Isotopes (ASPI) Accused of Deceiving Investors with Bogus Nuclear Tech Claims- Hagens Berman
San Francisco, California--(Newsfile Corp. - December 20, 2024) - ASP Isotopes Inc. (NASDAQ: ASPI) and certain of its most senior executives are now entangled in a securities class action, alleging the company deceived investors by making false and misleading statements about its advanced nuclear fuel technologies. Hagens Berman urges investors in ASP Isotopes who suffered substantial losses to submit your losses now. Class Period: Oct. 30, 2024 - Nov. 26, 2024 Lead Plaintiff Deadline: Feb....
2024-12-20 11:23 AM EST
Symbotic (SYM) Restates Financial Results Amid Securities Class Action Over Improper Accounting - Hagens Berman
San Francisco, California--(Newsfile Corp. - December 20, 2024) - On December 4, 2024, automation technology company Symbotic Inc. (NASDAQ: SYM) filed restated financial statements for the quarters ended December 30, 2023, March 30, 2024, and June 30, 2024 (the "restatements"). Each of the restatements contained adjustments to its previously filed financial reports for those periods that demonstrate Symbotic had significantly: (1) overstated its systems revenue; (2) overstated its gross...
2024-12-20 11:21 AM EST
Sezzle Inc. (SEZL) Shares Crash After Hindenburg Alleges Risky Practices - Hagens Berman
San Francisco, California--(Newsfile Corp. - December 20, 2024) - Sezzle Inc. (NASDAQ: SEZL), a buy now, pay later (BNPL) company, lost nearly a quarter of its market capitalization on December 18th following a damning report released by activist short seller Hindenburg Research, alleging that Sezzle has engaged in risky lending practices. Shareholder rights firm Hagens Berman has opened an investigation into the allegations to determine whether Sezzle may have violated the U.S. securities...
2024-12-20 11:19 AM EST
Investors Sue PACS Group (PACS) Amid Accusations of Medicare Fraud - Hagens Berman
San Francisco, California--(Newsfile Corp. - December 20, 2024) - PACS Group, Inc. (NYSE: PACS) and certain of its C-Suite officers are now entangled in a securities class action lawsuit, following allegations of misleading investors by engaging in deceptive Medicare practices. Hagens Berman urges investors in PACS Group who suffered substantial losses to submit your losses now. Class Period: Apr. 11, 2024 - Nov. 5, 2024 Lead Plaintiff Deadline: Jan. 13, 2025 Visit:...
2024-12-20 11:15 AM EST
Celsius Holdings (CELH) Hit with Investor Class Action Amid Accusations of Oversold Inventory to Pepsi- Hagens Berman
San Francisco, California--(Newsfile Corp. - December 20, 2024) - Celsius Holdings, Inc. (NASDAQ: CELH) and certain of its C-Suite officers are embroiled in a securities class action lawsuit, claiming they misrepresented and concealed crucial information about the company's financial performance, especially concerning its key customer, PepsiCo. Hagens Berman is investigating the allegations and urges investors in Celsius who purchased shares and suffered substantial losses to submit your...
2024-12-20 11:13 AM EST
Humacyte's (HUMA) Insiders Sell Millions in Stock Amidst Lawsuit and Regulatory Troubles - Hagens Berman
San Francisco, California--(Newsfile Corp. - December 18, 2024) - Humacyte insiders recently offloaded a significant portion of company stock, raising eyebrows amidst a brewing legal storm. According to recent SEC filings, Ayabudge LLC, an entity controlled by Board member Brady W. Dougan, who is married to CEO and President Laura Niklason, disposed of 1.5 million shares over three days in November, netting approximately $6.6 million. The sales, which were treated as indirectly benefiting Dr....
2024-12-18 6:50 PM EST
ASP Isotopes (ASPI) Accused of Deceiving Investors with Bogus Nuclear Tech Claims- Hagens Berman
San Francisco, California--(Newsfile Corp. - December 17, 2024) - ASP Isotopes Inc. (NASDAQ: ASPI) and certain of its most senior executives are now entangled in a securities class action, alleging the company deceived investors by making false and misleading statements about its advanced nuclear fuel technologies. Hagens Berman urges investors in ASP Isotopes who suffered substantial losses to submit your losses now. Class Period: Oct. 30, 2024 - Nov. 26, 2024 Lead Plaintiff Deadline: Feb....
2024-12-17 6:00 PM EST
Symbotic (SYM) Restates Financial Results Amid Securities Class Action Over Improper Accounting - Hagens Berman
San Francisco, California--(Newsfile Corp. - December 17, 2024) - On December 4, 2024, automation technology company Symbotic Inc. (NASDAQ: SYM) filed restated financial statements for the quarters ended December 30, 2023, March 30, 2024, and June 30, 2024 (the "restatements"). Each of the restatements contained adjustments to its previously filed financial reports for those periods that demonstrate Symbotic had significantly: (1) overstated its systems revenue; (2) overstated its gross...
2024-12-17 5:52 PM EST
Celsius Holdings (CELH) Hit with Investor Class Action Amid Accusations of Oversold Inventory to Pepsi- Hagens Berman
San Francisco, California--(Newsfile Corp. - December 17, 2024) - Celsius Holdings, Inc. (NASDAQ: CELH) and certain of its C-Suite officers are embroiled in a securities class action lawsuit, claiming they misrepresented and concealed crucial information about the company's financial performance, especially concerning its key customer, PepsiCo. Hagens Berman is investigating the allegations and urges investors in Celsius who purchased shares and suffered substantial losses to submit your...
2024-12-17 5:36 PM EST
Acadia Healthcare (ACHC) Class Action Pending with Expanded Class Period After Reporting Q3 Earnings, Disclosing SEC Subpoena - Hagens Berman Encourages ACHC Investors with $200k Losses to Contact the Firm Before Dec. 16, 2024 Deadline
San Francisco, California--(Newsfile Corp. - December 14, 2024) - Acadia Healthcare Company (NASDAQ: ACHC) is under fire as it faces a series of securities class-action lawsuits. Investors allege the company misled them about its business practices, with the most recent lawsuit, filed on December 10, 2024, expanding the class period to begin on Feb. 8, 2020 and end on October 30, 2024. This extension followed Acadia's Q3 2024 earnings report and reduced FY 2024 guidance, blaming slower...
2024-12-14 3:07 PM EST
BioAge Labs (BIOA) Azelaprag Trial Halt Raises Questions About Pre-IPO Disclosures - Hagens Berman
San Francisco, California--(Newsfile Corp. - December 13, 2024) - On December 9, 2024, just months after conducting an initial public offering in September 2024, BioAge Labs, Inc. (NASDAQ: BIOA) made the startling announcement that it was discontinuing a Phase 2 study for its lead product, azelaprag, intended to treat metabolic diseases such as obesity. Hagens Berman has opened an investigation and urges investors in BioAge who purchased shares in the company's IPO or on the open market and...
2024-12-13 3:31 PM EST
Investors Sue PACS Group (PACS) Amid Accusations of Medicare Fraud - Hagens Berman
San Francisco, California--(Newsfile Corp. - December 13, 2024) - PACS Group, Inc. (NYSE: PACS) and certain of its C-Suite officers are now entangled in a securities class action lawsuit, following allegations of misleading investors by engaging in deceptive Medicare practices. Hagens Berman urges investors in PACS Group who suffered substantial losses to submit your losses now. Class Period: Apr. 11, 2024 - Nov. 5, 2024 Lead Plaintiff Deadline: Jan. 13, 2025 Visit:...
2024-12-13 8:18 AM EST
ASP Isotopes (ASPI) Accused of Deceiving Investors with Bogus Nuclear Tech Claims- Hagens Berman
San Francisco, California--(Newsfile Corp. - December 11, 2024) - ASP Isotopes Inc. (NASDAQ: ASPI) and certain of its most senior executives are now entangled in a securities class action, alleging the company deceived investors by making false and misleading statements about its advanced nuclear fuel technologies. Hagens Berman urges investors in ASP Isotopes who suffered substantial losses to submit your losses now. Class Period: Oct. 30, 2024 - Nov. 26, 2024 Lead Plaintiff Deadline: Feb....
2024-12-11 6:02 PM EST
Symbotic (SYM) Accused of Misleading Investors with Inflated Revenues - Hagens Berman
San Francisco, California--(Newsfile Corp. - December 11, 2024) - Symbotic Inc. (NASDAQ: SYM), the automation technology company, is facing a securities fraud class action lawsuit after its stock price plummeted over 40% in a single day. The company's troubles began on November 27, 2024, when it alerted investors of a delay in filing its annual report and warned against the accuracy of previously submitted financial statements. Hagens Berman has opened an investigation and urges investors in...
2024-12-11 5:54 PM EST
Celsius Holdings (CELH) Hit with Investor Class Action Amid Accusations of Oversold Inventory to Pepsi- Hagens Berman
San Francisco, California--(Newsfile Corp. - December 11, 2024) - Celsius Holdings, Inc. (NASDAQ: CELH) and certain of its C-Suite officers are embroiled in a securities class action lawsuit, claiming they misrepresented and concealed crucial information about the company's financial performance, especially concerning its key customer, PepsiCo. Hagens Berman is investigating the allegations and urges investors in Celsius who purchased shares and suffered substantial losses to submit your...
2024-12-11 5:52 PM EST
Toronto-Dominion Bank (TD) Subsidiaries Plead Guilty to Violating Bank Secrecy Act and Conspiracy to Commit Money Laundering - Hagens Berman
San Francisco, California--(Newsfile Corp. - December 11, 2024) - On October 23, 2024, Moody's downgraded the long-term ratings of The Toronto-Dominion Bank (NYSE: TD) and its U.S. subsidiaries in response to the company's guilty plea earlier in the month to having engaged in a conspiracy to commit money laundering and agreement to pay a $3 billion fine. The ratings downgrade comes on the heels of a recently filed federal securities class action lawsuit against The Toronto-Dominion Bank and...
2024-12-11 5:51 PM EST
Humacyte's (HUMA) Statements to Investors Called Into Question in Light of FDA Violations - Hagens Berman
San Francisco, California--(Newsfile Corp. - December 11, 2024) - Humacyte, a biotechnology company focused on regenerative medicine, is now facing an investor class action alleging that the company misled investors about the status of its key product and the regulatory compliance of its manufacturing facilities. Hagens Berman urges investors in Humacyte (NASDAQ: HUMA) who suffered substantial losses to submit your losses now. Class Period: May 10, 2024 - Oct. 17, 2024 Lead Plaintiff...
2024-12-11 5:20 PM EST
Edwards Lifesciences (EW) Faces Investor Class Action Lawsuit Over TAVM Platform Disclosures, Deadline Pending - Hagens Berman
San Francisco, California--(Newsfile Corp. - December 10, 2024) - Investors in Edwards Lifesciences Corporation (NYSE: EW) contend that the medical device giant misled them about the growth prospects of its core product, the Transcatheter Aortic Valve Replacement (TAVR) platform. A class action lawsuit has been filed, accusing the company of securities fraud and claiming that executives painted a misleading picture of TAVR's future growth potential. Hagens Berman urges Edwards Lifesciences...
2024-12-10 6:35 PM EST